Axogen Reports Preliminary Unaudited Revenue for Fourth : vi

ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...

Related Keywords

United States , South Korea , Spain , Russia , Canada , Ukraine , United Kingdom , Germany , Haroldd Tamayo , Karen Zaderej , Nasdaq , Axogen Inc , Unaudited Fourth Quarter , Year End Performance , Core Accounts , Nerve Graft , Soft Tissue , Avive Soft Tissue , Axoguard Nerve , Nerve Protector , Private Securities Litigation Reform Act , Middle East , Annual Report , Quarterly Report , Nasdaq Axgn , Axogen , Nc , Allograft , Financial Results , Fourth Quarter , Vance , Nxgn ,